SciClone Pharmaceuticals, Inc. news

   Watch this stock
Showing stories 1 - 10 of about 82   

Articles published

SCLN 9.47 -0.11 (-1.15%)
price chart
Richard Hawkins an Insider in SciClone Pharmaceuticals, Inc. (NASDAQ:SCLN ...
The insider, and SciClone Pharmaceuticals, Inc. (NASDAQ:SCLN) 9.46 +0.02 0.21% 's director, Richard Hawkins, unloaded 11,982 company shares on May 26, 2015, valued by the market at around $113,145 (at $9.4 for each share).
Insider Selling: SciClone Pharmaceuticals Director Sells $113110.08 in Stock ...  Dakota Financial News
Analysts Set $8.00 Price Target for SciClone Pharmaceuticals (NASDAQ:SCLN)  sleekmoney
Why SciClone Pharmaceuticals, Inc. Is Surging Higher
Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis.
Notable 52-Week Highs and Lows 3/12: (AMRN) (DG) (SCLN) High; (PQ) (CNX ...  StreetInsider.com
Top 4 Small-Cap Stocks In The Drug Manufacturers-Other Industry With The ...  Benzinga
Stock Report on SciClone Pharmaceuticals Inc (NASDAQ:SCLN)
[Market Wired] SciClone Pharmaceuticals Inc (NASDAQ:SCLN)(TREND ANALYSIS) announced that it plans to report financial results for the first quarter 2015 on Monday, May 11, 2015.
Tuesday Pre-Market Thoughts: SciClone Pharmaceuticals, Inc. (SCLN), First ...  WallStreet Scope
SciClone Pharmaceuticals Inc.: SciClone Pharmaceuticals and Theravance ...
FOSTER CITY, CA and GEORGE TOWN, GRAND CAYMAN -- (Marketwired) -- 05/27/15 -- SciClone Pharmaceuticals (NASDAQ: SCLN), ("SciClone"), a U.S.-based, China-focused specialty pharmaceutical company, and Theravance Biopharma, Inc.
SciClone Pharmaceuticals and Theravance Biopharma Enter Into Development ...  MarketWatch
Theravance Biopharma and SciClone Pharmaceuticals Enter Into Development ...  CNNMoney
SciClone Pharmaceuticals, Inc. (NASDAQ:SCLN)'s Insider Friedhelm Blobel ...
The President & CEO of SciClone Pharmaceuticals, Inc. (NASDAQ:SCLN) 9.30 -0.53 -5.39% , Friedhelm Blobel has made an unexpected deal in the -listed company that is having a value of $90,667 U.S.
SciClone Pharmaceuticals CEO Sells $90700.00 in Stock (SCLN)  sleekmoney
SciClone Pharmaceuticals Inc. (SCLN) is Trading Higher on Unusual Volume for ...
SciClone Pharmaceuticals Inc. (SCLN) experienced unusually high volume on May. 20, as the stock gained 5.36% to a closing price of $9.83.
Insider Transaction: Chuncai Meng Unloaded 23660 Shares of SciClone ...
Company insider, Chuncai Meng, Gen. Counsel & VP Compliance of SciClone Pharmaceuticals, Inc. (NASDAQ:SCLN) 9.44 +0.14 1.51% unloaded a total of 23,660 shares of the company, estimated based on $9.6 for each share.
SciClone Pharmaceuticals CFO Lan Xie Sells 26668 Shares (SCLN)  Mideast Time
SciClone Pharmaceuticals Inc. (SCLN) Drops 5.39% on May 21
SciClone Pharmaceuticals Inc. (SCLN) was one of the Russell 2000's biggest losers for Thursday May 21 as the stock slid 5.39% to $9.30, a loss of $-0.53 per share.
Fair Value for SciClone Pharmaceuticals, Inc. (NASDAQ:SCLN)
SciClone Pharmaceuticals, Inc. (NASDAQ:SCLN) will report their fourth quarter earnings results on March 11. With that in mind, we look to see how the stock is priced based on current analyst expectations from a fundamental growth and value perspective.
SciClone Pharmaceuticals Inc. (SCLN) Hits New 52-week High During May 13 ...
SciClone Pharmaceuticals Inc. (SCLN) hit a new 52-week high yesterday, reaching a peak of $9.67 after opening at $9.53 and closing at $9.43 for a move of -1.05%.